105 related articles for article (PubMed ID: 23053256)
21. Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas.
Rhomberg W; Eiter H; Böhler F; Dertinger S
Anticancer Res; 2006; 26(3B):2407-11. PubMed ID: 16821624
[TBL] [Abstract][Full Text] [Related]
22. The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.
Nolan L; Darby A; Boleti K; Simmonds P
Breast; 2011 Apr; 20(2):151-4. PubMed ID: 20970333
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
24. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Chamberlain MC; Glantz MJ
Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
26. Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens.
Roland PY; Barnes MN; Niwas S; Robertson MW; Alvarez R; Austin JM; Kilgore LC; Partridge EE
Gynecol Oncol; 1998 Feb; 68(2):178-82. PubMed ID: 9514799
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
[TBL] [Abstract][Full Text] [Related]
28. [Simultaneous radiochemotherapy in recurrent and metastatic breast neoplasm. Clinical experience].
Plasswilm L; Sauer R
Strahlenther Onkol; 1995 Dec; 171(12):689-93. PubMed ID: 8545790
[TBL] [Abstract][Full Text] [Related]
29. A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors.
Fury MG; Sherman E; Haque S; Korte S; Lisa D; Shen R; Wu N; Pfister D
Cancer Chemother Pharmacol; 2012 Mar; 69(3):591-8. PubMed ID: 21913034
[TBL] [Abstract][Full Text] [Related]
30. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
Kolb EA; Kushner BH; Gorlick R; Laverdiere C; Healey JH; LaQuaglia MP; Huvos AG; Qin J; Vu HT; Wexler L; Wolden S; Meyers PA
J Clin Oncol; 2003 Sep; 21(18):3423-30. PubMed ID: 12972518
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.
Chawla SP; Staddon AP; Baker LH; Schuetze SM; Tolcher AW; D'Amato GZ; Blay JY; Mita MM; Sankhala KK; Berk L; Rivera VM; Clackson T; Loewy JW; Haluska FG; Demetri GD
J Clin Oncol; 2012 Jan; 30(1):78-84. PubMed ID: 22067397
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat model.
Perez J; Decouvelaere AV; Pointecouteau T; Pissaloux D; Michot JP; Besse A; Blay JY; Dutour A
PLoS One; 2012; 7(6):e32458. PubMed ID: 22761648
[TBL] [Abstract][Full Text] [Related]
33. Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.
Katz D; Azraq Y; Eleyan F; Gill S; Peretz T; Merimsky O
BMC Cancer; 2016 Aug; 16():616. PubMed ID: 27501793
[TBL] [Abstract][Full Text] [Related]
34. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
[No Abstract] [Full Text] [Related]
35. Outcome of advanced, unresectable conventional central chondrosarcoma.
van Maldegem AM; Gelderblom H; Palmerini E; Dijkstra SD; Gambarotti M; Ruggieri P; Nout RA; van de Sande MA; Ferrari C; Ferrari S; Bovée JV; Picci P
Cancer; 2014 Oct; 120(20):3159-64. PubMed ID: 24995550
[TBL] [Abstract][Full Text] [Related]
36. Recurrent low- to intermediate-grade chondrosarcoma of the thumb with lung metastases: an objective response to trofosfamide.
Debruyne PR; Dumez H; Demey W; Gillis L; Sciot R; Schöffski P
Onkologie; 2007 Apr; 30(4):201-4. PubMed ID: 17396043
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma.
Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163019
[TBL] [Abstract][Full Text] [Related]
38. Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.
Jones RL; Katz D; Loggers ET; Davidson D; Rodler ET; Pollack SM
Med Oncol; 2017 Aug; 34(10):167. PubMed ID: 28852958
[TBL] [Abstract][Full Text] [Related]
39. Advanced chondrosarcomas: role of chemotherapy and survival.
Italiano A; Mir O; Cioffi A; Palmerini E; Piperno-Neumann S; Perrin C; Chaigneau L; Penel N; Duffaud F; Kurtz JE; Collard O; Bertucci F; Bompas E; Le Cesne A; Maki RG; Ray Coquard I; Blay JY
Ann Oncol; 2013 Nov; 24(11):2916-22. PubMed ID: 24099780
[TBL] [Abstract][Full Text] [Related]
40. Incidence of anti-HLA donor specific antibodies in liver-transplant patients given mTOR inhibitors without calcineurin inhibitors.
Del Bello A; Congy-Jolivet N; Rostaing L; Kamar N
J Hepatol; 2014 Oct; 61(4):963-5. PubMed ID: 24999017
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
